332 results
8-K
EX-10.3
INVA
Innoviva Inc
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
Exhibit 10.3
TAX MATTERS AGREEMENT
by and between
THERAVANCE, INC.
and
THERAVANCE BIOPHARMA, INC.
Dated as of June 2, 2014
TABLE OF CONTENTS …
Page
Article I DEFINITIONS
Article II PREPARATION AND FILING OF TAX RETURNS
Section 2.1
Theravance’s Responsibility
Section 2.2
Biopharma’s
8-K
EX-99.1
xjvuii of99v
6 Feb 19
Innoviva Reports Fourth Quarter 2018 Financial Results
4:28pm
424B5
y0hce rvb
19 Mar 10
Prospectus supplement for primary offering
12:00am
424B5
ndzm tanzlqx
17 Mar 10
Prospectus supplement for primary offering
12:00am
S-3ASR
1589eo 1r6uv
15 Jan 08
Automatic shelf registration
12:00am
SC 14D9
EX-99
mfcuzdylqocjnjy
1 Aug 07
Tender offer solicitation
12:00am
SC TO-C
EX-99
wy35655crn
18 Jul 07
Information about tender offer
12:00am
SC TO-T
EX-99
xso2l
1 Aug 07
Third party tender offer statement
12:00am
SC TO-I
EX-99
9brz2yrk8g4m tze
1 Aug 07
Issuer tender offer statement
12:00am
SC TO-T
EX-99
4wed um89byjd7i
25 Jul 22
Third party tender offer statement
8:34am